Group V phospholipase A2 (gVPLA2) -induced eosinophil synthesis of LTC4 is independent of mitogen-activated protein kinases (MAPK) activation

N. M. Munoz, A. Y. Meliton, X. Zhu, W. Cho, A. R. Leff (Chicago, United States Of America)

Source: Annual Congress 2001 - Cellular and functional responses to exogenous stimuli
Session: Cellular and functional responses to exogenous stimuli
Session type: Thematic Poster Session
Number: 2767
Disease area: Airway diseases

Congress or journal article abstract

Rating: 0
You must login to grade this presentation.

Share or cite this content

Citations should be made in the following way:
N. M. Munoz, A. Y. Meliton, X. Zhu, W. Cho, A. R. Leff (Chicago, United States Of America). Group V phospholipase A2 (gVPLA2) -induced eosinophil synthesis of LTC4 is independent of mitogen-activated protein kinases (MAPK) activation. Eur Respir J 2001; 16: Suppl. 31, 2767

You must login to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.

Member's Comments

No comment yet.
You must Login to comment this presentation.


Related content which might interest you:
Activation of second messenger pathways in alveolar macrophages by endotoxin
Source: Eur Respir J 2002; 20: 210-222
Year: 2002



Regulation of cytokine- and phorbol ester-mediated interleukin (IL)-8 expression in the absence or presence of pyocyanin in human bronchial epithelial cell line: roles of protein kinase C and mitogen-activated protein kinases
Source: Eur Respir J 2005; 26: Suppl. 49, 99s
Year: 2005

Inhibition of p38 MAPK-dependent bronchial contraction after ozone by corticosteroids
Source: Eur Respir J 2011; 37: 933-942
Year: 2011



Thrombin activates mitogen activated protein (MAP) kinase and activated protein-1 (AP-1) to induce interleukin-8 (IL-8) release from airway epithelial cells
Source: Annual Congress 2003 - Mechanisms of lung injury: from bench to bedside
Year: 2003


Effect of fudosteine on mucin production
Source: Eur Respir J 2008; 32: 1195-1202
Year: 2008



LATE-BREAKING ABSTRACT: Evaluation of an oral p38 mitogen activated protein kinase (MAPK inhibitor) SB-681323 in COPD
Source: Annual Congress 2009 - COPD: from biomarker profiling to clinical assessment
Year: 2009


The effects of oral p38 mitogen activated protein kinase (MAPK) inhibitor SB-681323 on blood biomarkers in COPD
Source: Annual Congress 2008 - Novel treatments for respiratory disease
Year: 2008


Effect of smoking on MAP kinase-induced modulation of IL-8 in human alveolar macrophages
Source: Eur Respir J 2004; 23: 805-812
Year: 2004



Increased expression of p38 MAPK in human bronchial epithelium after lipopolysaccharide exposure
Source: Eur Respir J 2005; 25: 797-803
Year: 2005



Ventilation-induced activation of the mitogen-activated protein kinase pathway
Source: Eur Respir J 2002; 20: 946-956
Year: 2002



A novel mechanism for upregulation of β2-integrin and adhesion of eosinophils by secretory group V phospholipase A2 independent of cytosolic phospholipase A2 activation
Source: Annual Congress 2005 - Pulmonary hypertension and fibrosis: novel mechanisms
Year: 2005


Effects of glucocorticoids on activation of extracellular signal-regulated kinases (ERK) in human pulmonary endothelial cells
Source: Eur Respir J 2001; 18: Suppl. 33, 160s
Year: 2001

Transforming growth factor-α (TGF-α)-induced interleukin-8 (IL-8) release in human bronchial epithelial cells in vitro: role of mitogen-activated protein kinases (MAPK)
Source: Eur Respir J 2002; 20: Suppl. 38, 573s
Year: 2002

The inositol trisphosphate pathway mediates platelet-activating-factor-induced pulmonary oedema
Source: Eur Respir J 2005; 25: 849-857
Year: 2005



Intra-hemodialytic hypotension induces tumour necrosis factor-a (TNF-a) production to activate neutrophil mitogen-activated protein kinase (MAPK) in critical Ill patients
Source: Eur Respir J 2003; 22: Suppl. 45, 588s
Year: 2003

Role of p38 mitogen-activated protein kinase in trauma/hemorrhage and subsequent peumococcal pneumonia
Source: Annual Congress 2010 - Aetiology of lower respiratory tract infections and treatment in special situations
Year: 2010

Transforming growth factor-β inhibition of lung fibroblast proliferation is mediated through prostaglandin E2, via activation of p38 mitogen-activated protein kinase
Source: Annual Congress 2005 - Pulmonary hypertension and fibrosis: novel mechanisms
Year: 2005


Increased phosphorylated p38 mitogen-activated protein kinase in COPD lungs
Source: Eur Respir J 2013; 42: 28-41
Year: 2013



The pan janus kinase (JAK) inhibitor KN-002 suppresses inflammatory mediator release from severe asthma bronchial epithelial cells.
Source: Virtual Congress 2021 – Airway pharmacology: translational and basic science
Year: 2021